Cannabis sativa L. has been officially recognised as a medically legal medicinal plant in Switzerland since 1st of August 2022. Medicines containing THC and CBD can be prescribed by doctors with therapeutic freedom for the corresponding indications and are increasingly becoming a successful treatment option. Phytotherapy has thus regained a new, potent medicinal plant in its repertoire, which is also used in hard indications such as spasticity in multiple sclerosis, neuropathic pain or forms of paediatric epilepsy.

 

The monographs for cannabis flowers of PH HELV 12 CH311 and PH EUR 3028 provided the basis for the development of cannabis extracts and other formulations in the magistral formula area.

Cannabis pharmaceuticals represent a new challenge for pharmacies due to the highly dynamic nature of various stakeholders and demanding patients. At the same time, there are still regulatory hurdles in the implementation and qualitative aspects in the area of raw materials challenge pharmacists in the analytical in the analytical field. This training journal provides you with the knowledge you need to be prepared when you receive a prescription for medicinal cannabis or if you want to specialise your pharmacy accordingly.